AstraZeneca gets nod to launch cancer drug – Times of India
NEW DELHI: AstraZeneca Pharma India has obtained permission to import on the market and distribution of Durvalumab 120 mg/2.4 mL…
NEW DELHI: AstraZeneca Pharma India has obtained permission to import on the market and distribution of Durvalumab 120 mg/2.4 mL…
NEW DELHI: The Finances proposal to waive customs levy on three particular most cancers therapies has sparked claims of being…